UPDATE 1-AstraZeneca hopes to escape drug sales trough in second half By: Reuters: Company News April 27, 2017 at 03:43 AM EDT * Focus on pivotal lung cancer trial results due mid-year (Adds analyst comment, shares, detail on competitors) Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Merck & Co Rogers Corp